Soledad Casals, RN

Clinical Trials & Monitors Coordinator
Esteve Pharmaceuticals
Barcelona, Catalonia, Spain

Presentation(s):

• Poster Number-64 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study

  Poster Abstracts